Journavx (suzetrigine) was just recently approved by the FDA as the first sodium channel blocker pain medication. It is not an opioid. I have not been able to prescribe it yet to my patients, but I am interested in doing so. Hopefully the pharmacies where I practice will start carrying it. It will be nice to have an alternative to opioids, which carry the risk of addiction and issues with bowel motility. Topical CBD is becoming more and more popular with increasing research supporting its effica